Form4.ai tracks every SEC insider trade in real time. See every ROIV insider filing with a free account — no card.
See every ROIV insider filing — free account, no card.
Free accountRoivant Sciences Ltd. (ROIV) has 33 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $14.7M. Most recent filing: Oct. 30, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 30, 2026 SEC filing | Venker Eric President & Immunovant CEO | Sold | $7,318,000 | — |
| Oct 27, 2026 SEC filing | Oren Ilan Director | Grant / award | — | — |
| Oct 27, 2026 SEC filing | MOMTAZEE JAMES C Director | Vest & sell-to-cover | +306 sh | — |
Create a free account to see all 33 ROIV filings from the last 90 days. No card needed.
Create free accountWant ROIV insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.